Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  CEL-SCI Corporation    

CEL-SCI CORPORATION
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompanyFinancials 
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases.Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS).Multikine is... 
More about the company
Latest news on CEL-SCI CORPORATION
12:08pCEL SCI CORP : Other Events (form 8-K)
AQ
04/19CEL-SCI CORPORATION : to Present at The MicroCap Conference
AQ
04/12CEL SCI : Announces Adjustment to Warrant Exercise Price
AQ
04/09CEL SCI : NEW STORY CEL-SCI Corporation to Present at The Microcap Conference
PU
04/09CEL-SCI CORPORATION : to Present at The MicroCap Conference
BU
04/05CEL SCI CORP : Material Modification to Rights of Security Holders, Other Events..
AQ
04/04CEL-SCI CORPORATION : Issues Letter to Shareholders
BU
04/03CEL SCI : Announces Adjustment to Warrant Exercise Price
BU
02/26CEL SCI : Extends the expiration date of series dd and series ee warrants issued..
AQ
02/23CEL SCI : NEW STORY CEL-SCI Extends the Expiration Date of Series DD and Series ..
PU
More news
Sector news : Bio Therapeutic Drugs
06:55aGILEAD SCIENCES : The Million Dollar Cancer Treatment No One Knows How to Pay fo..
DJ
04/25Currency and pricing squeeze GSK as new shingles vaccine shines
RE
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
More sector news : Bio Therapeutic Drugs
Chart CEL-SCI CORPORATION
Duration : Period :
CEL-SCI Corporation Technical Analysis Chart | US1508374097 | 4-Traders
Managers
NameTitle
Geert R. Kersten Chief Executive Officer, Treasurer & Director
Patricia B. Prichep Secretary & Senior Vice President-Operations
Eyal Talor Chief Scientific Officer
Peter R. Young Independent Director
Bruno Jean Marie Baillavoine Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CEL-SCI CORPORATION26
GILEAD SCIENCES1.51%94 816
VERTEX PHARMACEUTICALS3.88%39 523
REGENERON PHARMACEUTICALS-17.01%33 601
GENMAB18.71%12 384
BEIGENE LTD (ADR)69.87%9 095